_exciting-times-for-hormone-sensitive-prostate-cancer-treatment-preview-1.jpg "Exciting times for hormone-sensitive prostate cancer treatment from olaparib prostate cancer Video Screenshot Preview 1")
Gallery_exciting-times-for-hormone-sensitive-prostate-cancer-treatment-preview-3.jpg "Exciting times for hormone-sensitive prostate cancer treatment from olaparib prostate cancer Video Screenshot Preview 3")
Gallery_exciting-times-for-hormone-sensitive-prostate-cancer-treatment-preview-hqdefault.jpg "Exciting times for hormone-sensitive prostate cancer treatment from olaparib prostate cancer Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 15 seconds
👁 View: 45 times
Play Audio:👁 View: 45 times
Description:
VJOncology
VJOncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_rucaparib-and-olaparib-two-new-treatments-approved-for-advanced-prostate-cancer-124-pcri.webp "Prostate Cancer Research Institute")
⏲ 5 minutes 15 seconds 👁 1.8K
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.webp "VJOncology")
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.webp "Medicine Matters oncology")
⏲ 3 minutes 41 seconds 👁 193
_niraparib-and-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.webp "ASCOcancer")
⏲ 2 minutes 59 seconds 👁 1.4K
_brca-amp-parp-inhibitors-targeted-chemotherapy-124-markscholzmd-alexscholz-pcri.webp "Prostate Cancer Research Institute")
⏲ 11 minutes 49 seconds 👁 2K
_recent-updates-in-prostate-cancer-stampede-vision-amp-profound.webp "VJOncology")
_propel-olaparib-plus-abiraterone-as-1l-treatment-for-metastatic-crpc.webp "VJOncology")
_what-is-lynparza-and-how-does-it-work-in-prostate-cancer-124-ask-a-prostate-expert-mark-scholz-md.webp "Prostate Cancer Research Institute")
⏲ 3 minutes 24 seconds 👁 2K
_rucaparib-and-olaparib-two-new-treatments-approved-for-advanced-prostate-cancer-124-pcri.jpg)
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.jpg)
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.jpg)
_niraparib-and-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.jpg)
_brca-amp-parp-inhibitors-targeted-chemotherapy-124-markscholzmd-alexscholz-pcri.jpg)
_recent-updates-in-prostate-cancer-stampede-vision-amp-profound.jpg)
_propel-olaparib-plus-abiraterone-as-1l-treatment-for-metastatic-crpc.jpg)
_what-is-lynparza-and-how-does-it-work-in-prostate-cancer-124-ask-a-prostate-expert-mark-scholz-md.jpg)
![[+]](/images/menu.gif){kind=small}